News

There's an overwhelming flood of retirement information targeted to higher -earning upper income Americans, but just about everyone else with more modest incomes are without the guidance to help make the best retirement decision..The budget blueprint now moves to the Senate, where leaders are expected to take it up as early as Monday. It will likely pass along party lines in that chamber too, with no anticipated support from Senate Democrats..This is a problem that affects retirees enrolled in Medicare Advantage plans much more so than those who have Medigap supplemental coverage which allows enrollees to see any provider that accepts Medicare. To reduce the costs of care, and to keep premiums low for consumers, Medicare Advantage plans contract with doctors and hospitals to create networks. Cost is a predominant concern and, in the process, plans create networks that exclude higher cost providers..So, I decide to put the bills back on the table and take out the trash first..Members of the Senate will return to Capitol Hill on September 6th, and Members of the House of Representatives will return on September 7th. TSCL would like to remind you to approach your Members of Congress at local events and request their support for a fair Social Security cost-of-living adjustment and other key issues..On the other hand under Medicaid, net drug prices are heavily influenced by two rebates that are required by law. Manufacturers of brand name drugs must pay a rebate equal to 23.1% of the average price that manufacturers charge to pharmacies. In addition, for generics, manufacturers are required to pay a rebate of 13% of the average price they charge to pharmacies..Congress Should Work Together to Strengthen Social Security.During these meetings, the following issues were discussed: Social Security cost-of-living adjustments, Social Security Notch fairness, Social Security Totalization agreement reform, and repeal of both the windfall elimination provision and the government pension offset. Support was expressed for many of these key issues, and TSCL looks forward to working with these offices in the future..Alzheimer's Drug Could Increase Part B Premiums for Everyone A newly approved drug to slow the progression of Alzheimer's disease is drawing criticism for it's ,000 price tag, especially given its lack of proven effectiveness. Aduhelm stirred controversy when the Food and Drug Administration's own expert advisory panel was nearly unanimous in opposing the drug's approval due to mixed results in studies of effectiveness.